Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

Star Mountain Resources, Inc. (SMRS) Reports Results of Evaluation of Exploration Targets in the Balmat-Edwards Mining District

Star Mountain Resources, Inc. (OTC: SMRS) today announced the results of its district-wide review and evaluation of the historic exploration drilling program that targeted zinc mineralization in the Balmat-Edwards Mining District, St. Lawrence County, New York. According to today’s press release, the company identified significant potential zinc mineralization in the Upper Marble unit (the host […]

Wild Cat OurPet’s Company (OPCO) is No Dog

OurPet’s Company (OTCQX: OPCO) may serve both cats and dogs with its innovative range of pet care solutions. However, the company itself is most definitely not a dog, as defined in the Boston Consulting Group’s (BCG) Growth Share Matrix. Rather, it’s a wild cat that has been churning out a string of ingenious pet care […]

Dominovas Energy Corp. (DNRG) Finalizing Plans to Deliver RUBICON™ ‘Showcase’ Unit to the University of Johannesburg

In a recent news release, Dominovas Energy Corp. (OTCQB: DNRG) announced that it is currently in the process of finalizing plans to deliver its proprietary RUBICON™ solid oxide fuel cell (SOFC) technology to the University of Johannesburg in South Africa. Deployment of the proposed ‘showcase’ unit, which was originally announced in May, will be a […]

 

From Our Blog

Lixte Biotech Holdings Inc. (NASDAQ: LIXT) Advances Precision Oncology Strategy with LB-100, Expands Clinical and Strategic Partnerships

April 9, 2026

Lixte Biotechnology (NASDAQ: LIXT) is emerging as a differentiated player in the oncology ecosystem, advancing a precision-driven approach to cancer treatment which focuses on improving the effectiveness of existing. As a clinical-stage pharmaceutical company, the company is advancing novel compounds built around a unique biological target, with its lead candidate, LB-100, at the nucleus of […]

Rotate your device 90° to view site.